Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Whitaker

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Medical Informatics|May 22, 2018
The impact of three discharge coding methods on the accuracy of diagnostic coding and hospital reimbursement for inpatient medical careRosy Tsopra, Daniel Peckham, Paul Beirne, et al.
Chemical Research in Toxicology|August 31, 2019
Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in VivoArun Tailor, James C Waddington, Jane Hamlett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2018
Correction: Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in PatientsXiaoli Meng, Zaid Al-Attar, Fiazia S Yaseen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2017
Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in PatientsXiaoli Meng, Zaid Al-Attar, Fiazia S Yaseen, et al.
Chemical Research in Toxicology|September 22, 2022
Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive PatientsAdriana Ariza, Kanoot Jaruthamsophon, Xiaoli Meng, et al.
Chemical Research in Toxicology|April 13, 2018
Up-Regulation of T-Cell Activation MicroRNAs in Drug-Specific CD4<sup>+</sup> T-Cells from Hypersensitive PatientsAlejandra Monroy-Arreola, Noé V Durán-Figueroa, Silvia Méndez-Flores, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 29, 2012
Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosisSabah El-Ghaiesh, Manal M Monshi, Paul Whitaker, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2011
Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosisAyman Elsheikh, Luis Castrejon, Sidonie N Lavergne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2011
Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosisPaul Whitaker, Xiaoli Meng, Sidonie N Lavergne, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 30, 2020
Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and PresentationJames C Waddington, Xiaoli Meng, Patricia T Illing, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Medical Informatics|May 22, 2018
The impact of three discharge coding methods on the accuracy of diagnostic coding and hospital reimbursement for inpatient medical careRosy Tsopra, Daniel Peckham, Paul Beirne, et al.
Chemical Research in Toxicology|August 31, 2019
Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in VivoArun Tailor, James C Waddington, Jane Hamlett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2018
Correction: Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in PatientsXiaoli Meng, Zaid Al-Attar, Fiazia S Yaseen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2017
Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in PatientsXiaoli Meng, Zaid Al-Attar, Fiazia S Yaseen, et al.
Chemical Research in Toxicology|September 22, 2022
Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive PatientsAdriana Ariza, Kanoot Jaruthamsophon, Xiaoli Meng, et al.
Chemical Research in Toxicology|April 13, 2018
Up-Regulation of T-Cell Activation MicroRNAs in Drug-Specific CD4<sup>+</sup> T-Cells from Hypersensitive PatientsAlejandra Monroy-Arreola, Noé V Durán-Figueroa, Silvia Méndez-Flores, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 29, 2012
Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosisSabah El-Ghaiesh, Manal M Monshi, Paul Whitaker, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2011
Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosisAyman Elsheikh, Luis Castrejon, Sidonie N Lavergne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2011
Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosisPaul Whitaker, Xiaoli Meng, Sidonie N Lavergne, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 30, 2020
Identification of Flucloxacillin-Haptenated HLA-B*57:01 Ligands: Evidence of Antigen Processing and PresentationJames C Waddington, Xiaoli Meng, Patricia T Illing, et al.
Pageof 6